Semaglutide vs NAD+: Detailed Comparison

Semaglutide (Ozempic/Wegovy) and NAD+ represent two very different approaches to metabolic health and longevity. One is an FDA-approved GLP-1 agonist with massive clinical trial data; the other is a cellular coenzyme with growing human trial support. Here's how they compare.

Educational purposes only. The information on this page is for educational and research purposes only. It does not constitute medical advice, diagnosis, or treatment. Research peptides are not FDA-approved for human therapeutic use unless explicitly stated. Always consult a licensed healthcare provider before using any compound.

Semaglutide

An FDA-approved GLP-1 receptor agonist — the most-studied peptide for weight loss

Full profile

NAD+

A critical coenzyme found in every cell — central to energy production and longevity research

Full profile

Criteria	Semaglutide	NAD+
Also Known As	Ozempic, Wegovy, Rybelsus	Nicotinamide Adenine Dinucleotide, NAD, β-NAD+
Primary Uses	Fat Loss, Hormonal Health	Longevity, Cognitive Performance
Research Status	Well-Studied	Well-Studied
FDA Status	FDA-Approved (Prescription)	Dietary Supplement (precursors) / Not FDA-approved as drug
Form	Injectable / Oral	Injectable / Oral
Human Studies	~200	~40
Animal Studies	~100	~200
Mechanism	Activates GLP-1 receptors in the pancreas (increasing insulin secretion), brain (reducing appetite), and gut (slowing gastric emptying) — creating a powerful multi-system effect on blood sugar and body weight.	Serves as a substrate for sirtuins (SIRT1–SIRT7) and PARPs — enzymes critical for DNA repair, gene expression, and cellular stress response. NAD+ declines with age; supplementation aims to restore youthful levels.
Stacks With	Tirzepatide	Epithalon, MOTS-c
Legal Status	FDA-approved prescription medication. Legal with a valid prescription. Compounded versions exist in a regulatory gray area.	Legal. Available as a dietary supplement (oral precursors NMN, NR). IV NAD+ requires clinical setting.

Benefits & Risks: Head to Head

Semaglutide

Benefits

Significant and sustained weight loss

Improved blood sugar control

Reduced cardiovascular events

Reduced appetite and food cravings

Risks

Nausea, vomiting, diarrhea (common, especially at initiation)

Pancreatitis (rare)

Thyroid C-cell tumor risk (seen in rodents — clinical significance unclear)

Muscle mass loss alongside fat loss

Rebound weight gain upon discontinuation

NAD+

Benefits

Increased energy levels

Improved cognitive clarity

Enhanced cellular repair

Improved sleep quality

Risks

Mild GI discomfort with oral forms

IV NAD+ can cause flushing, nausea during infusion

Theoretical concern about NAD+ fueling cancer cells (under research)

Cost of IV treatments is high

Affiliate link below — we may earn a commission if you purchase. This does not influence our research coverage.

View Semaglutide Suppliers (affiliate link)

Affiliate link below — we may earn a commission if you purchase. This does not influence our research coverage.

View NAD+ Suppliers (affiliate link)

Full Semaglutide Profile Full NAD+ Profile

← Back to Compare Tool